Catalyst Wire Dossier Catalyst Wire Dossier

A supplemental obstruction lessening venoactive drug

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A supplemental obstruction lessening venoactive drug, covering 2024-03-01 to 2024-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis [Phase 3]

See pricing